Advertisement

Topics

Partnership announced for the development of an oral cancer liquid biopsy test

11:12 EDT 19 Jun 2017 | EPM Magazine

MDxHealth and QUT bluebox (the commercialisation arm of the Queensland University of Technology) have signed a strategic agreement for the development of a liquid biopsy epigenetic assay for the early detection of oral cancer.

Original Article: Partnership announced for the development of an oral cancer liquid biopsy test

NEXT ARTICLE

More From BioPortfolio on "Partnership announced for the development of an oral cancer liquid biopsy test"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Epigenetics
The development and maintenance of an organism is orchestrated by a set of chemical reactions that switch parts of the genome off and on at strategic times and locations. Epigenetics is the study of these reactions and the factors that influence them. ...

Assays
An assay is an analytic procedure for qualitatively assessing or quantitatively measuring the presence or amount or the functional activity of a target entity.  This can be a drug or biochemical substance or a cell in an organism or organic sample. ...